Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3
Condition(s):Cervical Intraepithelial Neoplasia 3Last Updated:February 17, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Cervical Intraepithelial Neoplasia 3Last Updated:February 17, 2014Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:April 19, 2016Completed
Condition(s):Cervical Intraepithelial Neoplasia IIILast Updated:February 28, 2024Recruiting
Condition(s):Cervical CancerLast Updated:July 16, 2019Completed
Condition(s):Cervix Uteri SIL; HPV; CIN2; CIN3Last Updated:November 27, 2023Recruiting
Condition(s):CIN3; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 3; HPV 16 InfectionLast Updated:August 29, 2023Recruiting
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:March 17, 2016Unknown status
Condition(s):Gastroenteritis NorovirusLast Updated:February 6, 2024Completed
Condition(s):Cervical Cancer; Precancerous ConditionLast Updated:March 9, 2012Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:July 12, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.